Pleritioneal exudate cells treated with calcitonin gene-related peptide suppress murine experimental autiommune uveoretinitis via IL-10

Journal of Immunology

Volumn 173, Issue 2, 2004, Pages 1454-1462

  Kezuka, Takeshi ^a   Takeuchi, Masaru ^a   Keino, Hiroshi ^a   Usui, Yoshihiko ^a   Takeuchi, Aya ^a   Yamakawa, Noriyuki ^a   Usui, Masahiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BOVINE SERUM ALBUMIN; CALCITONIN GENE RELATED PEPTIDE; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; RETINA ANTIGEN; IMMUNOLOGICAL ADJUVANT;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DISEASE MODEL; EXPERIMENTAL AUTOIMMUNE UVEORETINITIS; FEMALE; HISTOPATHOLOGY; IMMUNIZATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PERITONEAL EXUDATE CELL; PRIORITY JOURNAL; SPLEEN CELL; SPLENECTOMY; T LYMPHOCYTE; UVEORETINITIS; ANIMAL; ASCITES FLUID; CYTOLOGY; IMMUNOLOGY; METABOLISM; RETINITIS; UVEITIS;

ADJUVANTS, IMMUNOLOGIC; ADOPTIVE TRANSFER; ANIMALS; ASCITIC FLUID; CALCITONIN GENE-RELATED PEPTIDE; INTERLEUKIN-10; MICE; RETINITIS; SPLENECTOMY; UVEITIS;

EID: 3142744604     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.2.1454     Document Type: Article

References (44)

1. Gery, I., B. Wiggert, T. M. Redmond, T. Kuwabara, M. A. Crawford, B. P. Vistica, and G. J. Chader. 1986. Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein. Invest. Ophthalmol. Visual Sci. 27:1296.
2. Mochizuki, M., T. Kuwabara, C. McAllister, R. B. Nussenblatt, and I. Gery. 1985. Adoptive transfer of experimental autoimmune uveoretinitis in rats: immunopathogenic mechanisms and histologic features. Invest. Ophthalmol. Visual Sci. 26:1.
3. Saoudi, A., J. Kuhn, K. Huygen, Y. de Kozak, T. Velu, M. Goldman, P. Druet, and B. Bellon. 1993. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur. J. Immunol. 23:3096.
4. Kezuka, T., J. Sakai, H. Yokoi, M. Takeuchi, A. Okada, O. Taguchi, M. Usui, and J. Mizuguchi. 1996. Peptide-mediated suppression of experimental autoimmune uveoretinitis in mice: development of a peptide vaccine. Int. Immunol. 8:1229.
5. Cousins, S. W., W. B. Trattler, and J. W. Streilein. 1991. Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye. Curr. Eye Res. 10:287.
6. Niederkorn, J. Y., J. L. Benson, and E. Mayhew. 1990. Efferent blockade of delayed-type hypersensitivity responses in the anterior chamber of the eye. Reg. Immunol. 3:349.
7. Streilein, J. W., M. Takeuchi, and A. W. Taylor. 1997. Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity. Hum. Immunol. 52:138.
8. Granstein, R. D., R. Staszewski, T. L. Knisely, E. Zeira, R. Nazareno, M. Latina, and D. M. Albert. 1990. Aqueous humor contains transforming growth factor-β and a small (less than 3500 daltons) inhibitor of thymocyte proliferation. J. Immunol. 144:3021.
9. Cousins, S. W., M. M. McCabe, D. Danielpour, and J. W. Streilein. 1991. Identification of transforming growth factor-β as an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Visual Sci. 32:2201.
10. Taylor, A. W., J. W. Streilein, and S. W. Cousins. 1992. Identification of α-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr. Eye Res. 11:1199.
11. Taylor, A. W., J. W. Streilein, and S. W. Cousins. 1994. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J. Immunol. 153:1080.
12. Zaidi, M., B. S. Moonga, P. J. Bevis, Z. A. Bascal, and L. H. Breimer. 1990. The calcitonin gene peptides: biology and clinical relevance. Crit. Rev. Clin. Lab. Sci. 28:109.
13. Stone, R. A., and A. M. McGlinn. 1988. Calcitonin gene-related peptide immunoreactive nerves in human and rhesus monkey eyes. Invest. Ophthalmol. Visual Sci. 29:305.
14. Tschopp, F. A., H. Henke, J. B. Petermann, P. H. Tobler, R. Janzer, T. Hokfelt, J. M. Lundberg, C. Cuello, and J. A. Fischer. 1985. Calcitonin gene-related peptide and its binding sites in the human central nervous system and pituitary. Proc. Natl. Acad. Sci. USA 82:248.
15. Abello, J., D. Kaiserlian, J. C. Cuber, J. P. Revillard, and J. A. Chayvialle. 1991. Characterization of calcitonin gene-related peptide receptors and adenylate cyclase response in the murine macrophage cell line P388 D1. Neuropeptides 19:43.
16. Boudard, F., and M. Bastide. 1991. Inhibition of mouse T-cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis. J. Neurosci. Res. 29:29.
17. Wang, F., I. Millet, K. Bottomly, and A. Vignery. 1992. Calcitonin gene-related peptide inhibits interleukin 2 production by murine T lymphocytes. J. Biol. Chem. 267:21052.
18. Asahina, A., J. Hosoi, S. Beissert, A. Stratigos, and R. D. Granstein. 1995. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. J. Immunol. 154:3056.
19. Torii, H., J. Hosoi, S. Beissert, S. Xu, F. E. Fox, A. Asahina, A. Takashima, A. H. Rook, and R. D. Granstein. 1997. Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptide. J. Leukocyte Biol. 61:216.
20. Niizeki, H., P. Alard, and J. W. Streilein. 1997. Calcitonin gene-related peptide is necessary for ultraviolet B-impaired induction of contact hypersensitivity. J. Immunol. 159:5183.
21. Kitazawa, T., and J. W. Streilein. 2000. Hapten-specific tolerance promoted by calcitonin gene-related peptide. J. Invest. Dermatol. 115:942.
22. Wilbanks, G. A., and J. W. Streilein. 1992. Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties. Reg. Immunol. 4:130.
23. Wilbanks, G. A., and J. W. Streilein. 1992. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-β. Eur. J. Immunol. 22:1031.
24. Wilbanks, G. A., M. Mammolenti, and J. W. Streilein. 1992. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-β. Eur. J. Immunol. 22:165.
25. Avichezer, D., P. B. Silver, C. C. Chan, B. Wiggert, and R. R. Caspi. 2000. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype. Invest. Ophthalmol. Visual Sci. 41:127.
26. Taylor, A. W., P. Alard, D. G. Yee, and J. W. Streilein. 1997. Aqueous humor induces transforming growth factor-β (TGF-β)-producing regulatory T-cells. Curr. Eye Res. 16:900.
27. Chan, C. C., R. R. Caspi, M. Ni, W. C. Leake, B. Wiggert, G. J. Chader, and R. B. Nussenblatt. 1990. Pathology of experimental autoimmune uveoretinitis in mice. J. Autoimmun. 3:247.
28. Suh, E. D., B. P. Vistica, C. C. Chan, J. M. Raber, I. Gery, and R. B. Nussenblatt. 1993. Splenectomy abrogates the induction of oral tolerance in experimental autoimmune uveoretinitis. Curr. Eye Res. 12:833.
29. Streilein, J. W., J. Y. Niederkorn, and J. A. Shadduck. 1980. Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens. J. Exp. Med. 152:1121.
30. Streilein, J. W., and S. W. Cousins. 1990. Aqueous humor factors and their effect on the immune response in the anterior chamber. Curr. Eye Res. 9(Suppl.):175.
31. + T cells similar to those found in mice with anterior chamber-associated immune deviation. Invest. Ophthalmol. Visual Sci. 41:1803.
32. D'Orazio, T. J., and J. Y. Niederkorn. 1998. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology 95:47.
33. Hara, Y., R. R. Caspi, B. Wiggert, M. Dorf, and J. W. Streilein. 1992. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye. J. Immunol. 149:1531.
34. Taylor, A. W., D. G. Yee, and J. W. Streilein. 1998. Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor. Invest. Ophthalmol. Visual Sci. 39:1372.
35. Taylor, A. W., and D. G. Yee. 2003. Somatostatin is an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Visual Sci. 44:2644.
36. Hara, Y., R. R. Caspi, B. Wiggert, C. C. Chan, G. A. Wilbanks, and J. W. Streilein. 1992. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein. J. Immunol. 148:1685.
37. Streilein, J. W., and J. Y. Niederkorn. 1981. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J. Exp. Med. 153:1058.
38. Niizeki, H., and J. W. Streilein. 1997. Hapten-specific tolerance induced by acute, low-dose ultraviolet B radiation of skin is mediated via interleukin-10. J. Invest. Dermatol. 109:25.
39. Takeuchi, M., H. Yokoi, R. Tsukahara, I. Sakai, and M. Usui. 2001. Differentiation of Th1 and Th2 cells in lymph nodes and spleens of mice during experimental autoimmune uveoretinitis. Jpn. J. Ophthalmol. 45:463.
40. Rizzo, L. V., H. Xu, C. C. Chan, B. Wiggert, and R. R. Caspi. 1998. IL-10 has a protective role in experimental autoimmune uveoretinitis. Int. Immunol. 10:807.
41. + TH1-like responses. J. Clin. Invest. 98:1010.
42. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J. Exp. Med. 184:241.
43. Tzachanis, D., A. Berezovskaya, L. M. Nadler, and V. A. Boussiotis. 2002. Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses. Blood 99:1465.
44. Tamura, H., H. Dong, G. Zhu, G. L. Sica, D. B. Flies, K. Tamada, and L. Chen. 2001. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 97:1809.